Melanoma and Skin Cancer
FDA Approves Sonidegib for Basal Cell Carcinoma
Read More >>
View Free CME from PER >>
Regulatory Filings Move Dabrafenib/Trametinib Combo Closer to Full Melanoma Approval
Selumetinib Misses Endpoint in Phase III Uveal Melanoma Study
European Commission Approves Pembrolizumab for Advanced Melanoma
A Focus on Pathways: Evolving Role of Oncolytic Immunotherapy in Melanoma
Targeted Therapies, Combination Protocols Are Revolutionizing Treatment for Advanced Melanoma
View More >>
See the latest in research and cutting edge developments from our partner institutions
- A Network of Your Peers
View more >>
Dr. Jeffrey Trent on the Melanoma Dream Team
Dr. Sekulic on Molecular Testing in Advanced Melanoma
Dr. Arkenau on Dabrafenib Combined With Trametinib for BRAF-mutated Melanoma
Dr. Ernstoff Discusses Nivolumab and Ipilimumab in Advanced Melanoma
Closing Comments: Updates in Malignant Melanoma
In this segment, the panel members share their final thoughts on the progress made to date in malignant melanoma.
Emerging Therapies for Malignant Melanoma
In this segment, Omid Hamid, MD leads the panel in a discussion about novel therapies in development for melanoma.
Practical Considerations in Metastatic Melanoma
Moderated by Mario Sznol, MD, with expert perspectives from Robert H. I. Andtbacka, MD, CM, Omid Hamid, MD, Merrick I. Ross, MD, Jeffrey A. Sosman, MD, and Jeffrey S. Weber, MD, PhD.
Medical Crossfire®: Recent Advances in the Treatment of Metastatic Melanoma
CME activity worth 1.0 CME credits by Keith T. Flaherty, MD, Jeffrey S. Weber, MD, PhD, and Jedd D. Wolchok, MD, PhD.
Most Popular Right Now
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2015
Intellisphere, LLC. All Rights Reserved.